Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Advitech Solutions, Pierre Jouan Biotechnologie Sign Agreement - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Advitech Solutions, Pierre Jouan Biotechnologie Sign Agreement

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Advitech Solutions, Quebec, Canada, has entered into an exclusive agreement with Pierre Jouan Biotechnologie SA of France. This agreement gives Advitech exclusive rights to the technology that Jouan Biotechnologie has developed for applications for the treatment of psoriasis and other similar immune system disorders and covers, among others, the North American and Japanese markets. The French technology is based on the activity of bioactive peptides obtained from an enriched whey protein fraction and uses a patent-pending process. Advitech will apply this technology to its program for the development of a nutraceutical solution for psoriasis.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters